IntegraGen SA (EPA:ALINT)

IntegraGen Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-2.66	-	-	-	-
Depreciation & Amortization	0.04	-	-	-	-
Other Operating Activities	0.33	-	-	-	-
Change in Inventory	0.09	-	-	-	-
Change in Other Net Operating Assets	0.62	-	-	-	-
Operating Cash Flow	-1.58	-	-	-	-
Capital Expenditures	-0	-	-	-	-
Investment in Securities	0.04	-	-	-	-
Investing Cash Flow	0.04	-	-	-	-
Short-Term Debt Issued	1.09	-	-	-	-
Total Debt Issued	1.09	-	-	-	-
Long-Term Debt Repaid	-0.34	-	-	-	-
Net Debt Issued (Repaid)	0.75	-	-	-	-
Financing Cash Flow	0.75	-	-	-	-
Miscellaneous Cash Flow Adjustments	-0	-	-	-	-
Net Cash Flow	-0.79	-	-	-	-
Free Cash Flow	-1.58	-	-	-	-
Free Cash Flow Margin	-31.43%	-	-	-	-
Free Cash Flow Per Share	-0.24	-	-	-	-
Levered Free Cash Flow	-0.17	-	-	-	-
Unlevered Free Cash Flow	-0.16	-	-	-	-
Change in Working Capital	0.71	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 2, 2026

Data Sources Report a data error